RBC Capital Reiterates Outperform on Design Therapeutics, Maintains $24 Price Target
RBC Capital analyst Leonid Timashev reiterates Design Therapeutics (NASDAQ:DSGN) with a Outperform and maintains $24 price target.
Benchmark Reiterates Buy on Porch Group, Maintains $14 Price Target
Benchmark analyst Daniel Kurnos reiterates Porch Group (NASDAQ:PRCH) with a Buy and maintains $14 price target.
Benchmark Reiterates Buy on Westrock Coffee, Maintains $15 Price Target
Benchmark analyst Todd Brooks reiterates Westrock Coffee (NASDAQ:WEST) with a Buy and maintains $15 price target.
Credit Suisse Reiterates Outperform on Oracle, Maintains $115 Price Target
Credit Suisse analyst Sami Badri reiterates Oracle (NYSE:ORCL) with a Outperform and maintains $115 price target.
Credit Suisse Reiterates Neutral on Tritium DCFC, Maintains $3 Price Target
Credit Suisse analyst Maheep Mandloi reiterates Tritium DCFC (NASDAQ:DCFC) with a Neutral and maintains $3 price target.
HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $17 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $17 price target.
Needham Reiterates Buy on SentinelOne, Maintains $19 Price Target
Needham analyst Alex Henderson reiterates SentinelOne (NYSE:S) with a Buy and maintains $19 price target.
HC Wainwright & Co. Reiterates Buy on Tarsus Pharmaceuticals, Maintains $40 Price Target
HC Wainwright & Co. analyst Oren Livnat reiterates Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and maintains $40 price target.
Needham Reiterates Buy on Super Group (SGHC), Maintains $5 Price Target
Needham analyst Bernie McTernan reiterates Super Group (SGHC) (NYSE:SGHC) with a Buy and maintains $5 price target.
Telsey Advisory Group Reiterates Outperform on Grove Collaborative Hldgs, Maintains $3 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Grove Collaborative Hldgs (NYSE:GROV) with a Outperform and maintains $3 price target.